Cervical dysplasia is characterized by an abnormal growth of endocervical canal cells. Cervical dysplasia is also called as cervical intraepithelial neoplasia. It is a Sexually Transmitted Disease (STD) caused due to human papillomavirus (HPV) infection. Cervical dysplasia can affect two types based on the type of cells it affects – squamous intraepithelial lesions and glandular cell lesions. It occurs in all age groups and it is common in women with 30 years age.
Click To Continue Reading On Cervical Dysplasia Diagnostic Market
Cervical dysplasia can be detected by Pap test, endocervical curettage, and loop electrosurgical excision procedure (LEEP) or HPV DNA test. The cervical dysplasia diagnostic screening program for human papillomavirus is widely available.
Cervical infection is major risk factor for progression of HPV. Currently, conventional Pap smear test or HPV test are the only test available for screening of cervical infection, which in turn requires DNA-based molecular testing to detect human papillomavirus for diagnosis of cervical cancer. For instance, in 2016, Becton, Dickinson and Company received pre-diagnostic market approval from FDA for its Onclarity HPV assay, type of HPV test.
However, current practices for cervical dysplasia diagnostic through colposcopy requires trained professional to perform the test, which is major challenge for growth of the market. To overcome this, research institutes and universities are involved in the development of innovative diagnostic devices, which are driving in the growth of the cervical dysplasia diagnostic market. For instance, in July 2017, Duke University in North Carolina developed a pocket colposcopy device enable with laptop and mobile connection. The device was funded by National Institutes of Health (NIH).
On the basis of region, cervical dysplasia diagnostic market is segmented into North America, Europe, Asia Pacific, South America, and Middle East. Increasing awareness regarding cervical dysplasia screening programs and technological advances in screening the key factors. Moreover, market in Asia Pacific region is expected to report significant growth over the forecast period, owing to increasing government funding for cervical research and improving healthcare infrastructure.
Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1486
Key vendors:
Abbott Laboratories, Qiagen NV, Hologic Inc., F. Hoffmann La-Roche Ltd., Quest Diagnostics Inc., Becton, Dickinson and Company, Atmos, and Karl Kaps.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through emerging market trends, technologies, and potential absolute dollar opportunities.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, # 3200
Seattle, WA 98154
Tel: + 1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit our news site: https://www.coherenttimes.org/